Literature DB >> 25487942

Cucurbitacin-B inhibits neuroblastoma cell proliferation through up-regulation of PTEN.

Y Shang1, X-X Guo, W-W Li, W Rao, M-L Chen, L-N Mu, S-J Li.   

Abstract

OBJECTIVE: Cucurbitacins belong to a class of highly oxidized tetracyclic triterpenoids. Recent studies suggest that the use of Cucurbitacin could repress cancer cell progression. However, the biological effect of Cucurbitacin-B in neuroblastoma cells remains unexplored.
MATERIALS AND METHODS: MTT and BrdU (bromodeoxyuridine) incorporation assays were used to determine the anti-proliferation roles of Cucurbitacin-B. Real-time PCR and Western blot assays were used to detect the expression of cell cycle regulators. Small interfering RNAs (siRNAs) were used to silence the expression of PTEN (phosphatase and tensin homolog gene).
RESULTS: We found that Cucurbitacin-B inhibited growth and modulated expression of cell-cycle regulators in SHSY5Y cells. At the molecular level, we found that Cucurbitacin-B inhibited AKT signaling activation through up-regulation of PTEN. Indeed, PTEN deficiency using siRNA oligos attenuated the anti-proliferative roles of Cucurbitacin-B.
CONCLUSIONS: These results provide evidence for a mechanism that may contribute to the antineoplastic effects of Cucurbitacin-B in neuroblastoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25487942

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  11 in total

1.  Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.

Authors:  Yener Kurman; Ilker Kiliccioglu; Asiye U Dikmen; Guldal Esendagli; Cenk Y Bilen; Sinan Sozen; Ece Konac
Journal:  Exp Biol Med (Maywood)       Date:  2020-04-06

2.  Role and mechanism of miR-222 in arsenic-transformed cells for inducing tumor growth.

Authors:  Min Wang; Xin Ge; Jitai Zheng; Dongmei Li; Xue Liu; Lin Wang; Chengfei Jiang; Zhumei Shi; Lianju Qin; Jiayin Liu; Hushan Yang; Ling-Zhi Liu; Jun He; Linlin Zhen; Bing-Hua Jiang
Journal:  Oncotarget       Date:  2016-04-05

3.  PTEN Activation by DNA Damage Induces Protective Autophagy in Response to Cucurbitacin B in Hepatocellular Carcinoma Cells.

Authors:  Yanan Niu; Wen Sun; Jin-Jian Lu; Dik-Lung Ma; Chung-Hang Leung; Lixia Pei; Xiuping Chen
Journal:  Oxid Med Cell Longev       Date:  2016-11-30       Impact factor: 6.543

4.  CD164 regulates proliferation and apoptosis by targeting PTEN in human glioma.

Authors:  Ming Tu; Lin Cai; Weiming Zheng; Zhipeng Su; Yong Chen; Songtao Qi
Journal:  Mol Med Rep       Date:  2017-02-15       Impact factor: 2.952

5.  Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells.

Authors:  Yingchun Qu; Peifang Cong; Chengjiang Lin; Yihui Deng; Jesse Li-Ling; Meixia Zhang
Journal:  Oncol Lett       Date:  2017-05-10       Impact factor: 2.967

6.  Cucurbitacin E inhibits cellular proliferation and enhances the chemo-response in gastric cancer by suppressing AKt activation.

Authors:  Wenzhang Si; Jia Lyu; Zhengchuang Liu; Chunyang Wang; Jingjing Huang; Liping Jiang; Tonghui Ma
Journal:  J Cancer       Date:  2019-10-06       Impact factor: 4.207

7.  Silencing Of MAGI1 Promotes The Proliferation And Inhibits Apoptosis Of Glioma Cells Via The Wnt/β-Catenin And PTEN/AKT Signaling Pathways.

Authors:  Yongzhi Lu; Wei Sun; Liang Zhang; Junyao Li
Journal:  Onco Targets Ther       Date:  2019-11-13       Impact factor: 4.147

8.  Lentivirus-mediated shRNA interference of ghrelin receptor blocks proliferation in the colorectal cancer cells.

Authors:  An Liu; Chenggang Huang; Jia Xu; Xuehong Cai
Journal:  Cancer Med       Date:  2016-07-27       Impact factor: 4.452

Review 9.  Recent advances in biosynthesis of bioactive compounds in traditional Chinese medicinal plants.

Authors:  Lei Yang; Changqing Yang; Chenyi Li; Qing Zhao; Ling Liu; Xin Fang; Xiao-Ya Chen
Journal:  Sci Bull (Beijing)       Date:  2015-11-02       Impact factor: 11.780

10.  An Autophagy-Related Gene Signature Associated With Clinical Prognosis and Immune Microenvironment in Gliomas.

Authors:  Yang Xu; Renpeng Li; Xiaoxia Li; Naijun Dong; Di Wu; Lin Hou; Kan Yin; Chunhua Zhao
Journal:  Front Oncol       Date:  2020-10-19       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.